Onconova Presents Data on Dual Inhibitor of CDK4/6 + ARK5 at American Association for Cancer Research 2018 Annual Meeting

NEXT STORY
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
PREV STORY
Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mateon Announces Initiation of Investigator-Sponsored Phase 1 Study of CA4P in Combination with Everolimus in Neuroendocrine Tumors

SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), ...

author_avatar
NASDAQ Market News

Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial  

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or ...

author_avatar
NASDAQ Market News

Cancer Genetics Announces Timing for Third Quarter 2017 Earnings Call & Update on vivoPharm Integration on Thursday, November 9th

RUTHERFORD, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) a leader ...

author_avatar
NASDAQ Market News